Dr Reddys Laboratories (RDY) Short-term Investments (2018 - 2026)

Dr Reddys Laboratories (RDY) has reported Short-term Investments for 9 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• Quarterly Short-term Investments fell 71.43% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 71.43% YoY) and the FY2026 annual result came in at $2.0 million, down 71.43% from the prior year.
• Short-term Investments fell to $2.0 million in Q1 2026 per RDY's latest filing, from $7.0 million in the prior quarter.
• Over the last five years, Short-term Investments for RDY reached as high as $389.0 million in Q1 2022 and fell as low as $2.0 million in Q1 2024.
• A 5-year average of $83.0 million and a median of $7.0 million in 2025 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments surged 2188.24% — and 2023, when it sank 96.14%.
• Year by year, Short-term Investments stood at $389.0 million in 2022, then slumped by 96.14% to $15.0 million in 2023, then tumbled by 86.67% to $2.0 million in 2024, then jumped by 250.0% to $7.0 million in 2025, then slumped by 71.43% to $2.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $2.0 million, $7.0 million, and $2.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.